The effect of age on the pharmacokinetics of pentazocine

Area of Science:

• Pharmacology
• Geriatric Medicine
• Clinical Pharmacy

Background:

• Pentazocine is an analgesic commonly used in surgical patients.
• Age-related changes in drug metabolism can significantly alter pharmacokinetic profiles.
• Understanding these changes is crucial for optimizing drug therapy in elderly populations.

Purpose of the Study:

• To investigate the effect of age on the pharmacokinetics of intravenously administered pentazocine.
• To determine how pentazocine clearance and elimination half-life differ between young and elderly surgical patients.
• To provide insights into age-related modifications in pentazocine dosage regimens.

Main Methods:

• Intravenous administration of pentazocine to 18 subjects (surgical patients and volunteers).
• Subjects were divided into two age groups: young (22-48 years) and elderly (60-90 years).
• Pharmacokinetic parameters, including total clearance and elimination half-life, were analyzed and compared between groups.

Main Results:

• Total pentazocine clearance significantly decreased with age, from 22.14 +/- 4.114 ml/min/kg in the young group to 11.68 +/- 3.593 ml/min/kg in the elderly group.
• The elimination half-life of pentazocine increased with age, from 2.5 +/- 0.71 hours in the young group to 4.11 +/- 1.187 hours in the elderly group.
• No significant change in the apparent volume of distribution was observed between the age groups.

Conclusions:

• Age significantly impacts pentazocine pharmacokinetics, leading to reduced clearance and prolonged half-life in elderly individuals.
• These pharmacokinetic alterations necessitate careful consideration when designing pentazocine dosage regimens for the elderly to ensure safety and efficacy.
• Further research may be warranted to establish specific age-adjusted dosing guidelines for pentazocine.